Lot A. Devriese

Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

Else Driehuis, Sigrid Kolders, Sacha Spelier et al. · Cancer Discovery · 2019 · 399 citations · Full text

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Suzanne L. Topalian, Shailender Bhatia, Asim Amin et al. · Journal of Clinical Oncology · 2020 · 265 citations · Full text

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart et al. · Nature · 2019 · 252 citations · Full text

Drug Repositioning, Oncology, Preclinical Drug Evaluation +11

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Robert L. Ferris, William C. Spanos, Rom S. Leidner et al. · Journal for ImmunoTherapy of Cancer · 2021 · 205 citations · Full text

Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)

Emma J. de Ruiter, Frans J. Mulder, Bregje M Koomen et al. · Modern Pathology · 2020 · 138 citations · Full text

Tumor Biology, Pd-l1 Immunohistochemical Assays, Cancer Immunosurveillance +9